Intravenous immunoglobulin (IVIG) is an antibody-based therapy used as a first-line treatment for immune thrombocytopenia (ITP). It works by interfering with the immune system’s ability to destroy platelets, helping to quickly raise platelet levels and reduce the risk of bleeding.
Immune thrombocytopenia
Whether you're newly diagnosed with ITP or have been managing it for some time, these resources offer guidance on symptoms, treatment options, and emotional support to help you move forward with confidence.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
Corticosteroids are medications with powerful anti-inflammatory and immunosuppressive properties that are often the first-line treatment for immune thrombocytopenia. They help reduce the immune system’s attack on platelets, increasing platelet levels and lowering the risk of bleeding.
